GILD Nov 2024 80.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:47PM EDT. Market open.
| Previous close | 0.7900 |
| Open | 0.8500 |
| Bid | 0.7200 |
| Ask | 0.7900 |
| Strike | 80.00 |
| Expiry date | 2024-11-15 |
| Day's range | 0.7900 - 0.8500 |
| Contract range | N/A |
| Volume | |
| Open interest | 162 |
Simply Wall St.Gilead Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Gilead Sciences ( NASDAQ:GILD ) First Quarter 2024 Results Key Financial Results Revenue: US$6.69b (up 5.3% from 1Q...
Investor's Business DailyGilead Gives Up Big Gains As Covid Drug Drives Its Beat — Again
Gilead stock pared its gains Friday after beating first-quarter sales forecasts on the back of its Covid treatment, Veklury.
ZacksGilead (GILD) Q1 Loss Narrower Than Expected, Sales Beat
Gilead (GILD) reports narrower-than-expected loss in the first quarter. Its sales beat estimates on higher HIV, Oncology and Liver Disease sales.
© 2024 Yahoo. All rights reserved.